Global Antiviral Drugs Market Size, Trends & Growth Opportunity, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Type (Branded, Generics), By Application, and Forecast till 2027.
Global Antiviral Drugs Market
The global Antiviral Drugs Market was valued at USD 63.5 billion in 2021 which expected to reach USD 64.0 billion by 2027 at a CAGR 1% from 2021-2027.
The Qualiket Research offers in-depth analysis, revenue details, and other important information regarding the Antiviral Drugs Market, and the various trends, drivers, restraints. A top-down & bottom-up approaches were employed in the preparation of the report on Antiviral Drugs Market. The overall report has been sectioned into an overview of the Antiviral Drugs Market, segmental outline, regional analysis, competitive dashboard, and the recent market updates. The Antiviral Drugs Market overview has been categorized into market statistics as well as the market highlights. Proficient analysts applied modern research methodologies for extensive primary & secondary research on the Antiviral Drugs Market.
The market statistics segment briefs on the forecasted CAGR the Antiviral Drugs Market is anticipated to register over the review period and the valuation it can attain by the end year. The market highlights details boosters and restraints, which can influence the target market growth over the forecast period. Skilled market analysts have meticulously worked on the evolution of the Antiviral Drugs Market and have identified the recent trends reinforcing the Antiviral Drugs Market growth. They have also spotted every opportunity based on that the market can capitalize
The market overview was noted on a zero-deviation approach & have maintained excellent quality research techniques throughout the Antiviral Drugs Market analysis. The segmental outline targets facets of the Antiviral Drugs Market. The regional analysis of the Antiviral Drugs Market provides an idea regarding the regional progress of the Antiviral Drugs Market as well as the identification of growth windows. In addition, the key vendors of the Antiviral Drugs Market have been segregated on a regional basis. Interviews with key people of the Antiviral Drugs Market and other credible sources like whitepaper are referred for designing the key operating players section. Furthermore, finally, the Antiviral Drugs Market update section mentions the recent key developments in the Antiviral Drugs Market
The report also helps in understanding Antiviral Drugs Market dynamics, structure by analyzing the market segments and projects the Antiviral Drugs Market. Overall representation of competitive analysis of key operating players by financial position, Product portfolio, growth strategies, as well as the regional presence in the Antiviral Drugs Market make the report investor’s guide.
Key Players:
The key players profiled in the Leavening Agents market report Gilead Sciences, Inc.; GlaxoSmithKline plc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Merck & Co., Inc.; Johnson & Johnson Services, Inc.; Cipla Inc.; Aurobindo Pharma; Dr. Reddy’s Laboratories Ltd.
Market Taxonomy
By Drug Class
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protease Inhibitors
Neuraminidase Inhibitors
Others
By Type
Branded
Generics
By Application
HIV
Hepatitis
Herpes
Influenza
Others
By Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
- 1 Introduction
- 1.1 Objective of the Study
- 1.2 Market definition
- 1.3 Market Scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global Antiviral Drugs Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Antiviral Drugs Market, By Drug Class
- 5.1 Y-o-Y Growth Comparison, By Drug Class
- 5.2 Global Antiviral Drugs Market Share Analysis, By Drug Class
- 5.3 Global Antiviral Drugs Market Size and Forecast, By Drug Class
- 5.3.1 DNA Polymerase Inhibitors
- 5.3.2 Reverse Transcriptase Inhibitors
- 5.3.3 Protease Inhibitors
- 5.3.4 Neuraminidase Inhibitors
- 5.3.5 Others
- 6 Global Antiviral Drugs Market, By Type
- 6.1 Y-o-Y Growth Comparison, By Type
- 6.2 Global Antiviral Drugs Market Share Analysis, By Type
- 6.3 Global Antiviral Drugs Market Size and Forecast, By Type
- 6.3.1 Branded
- 6.3.2 Generics
- 7 Global Antiviral Drugs Market, By Application
- 7.1 Y-o-Y Growth Comparison, By Application
- 7.2 Global Antiviral Drugs Market Share Analysis, By Application
- 7.3 Global Antiviral Drugs Market Size and Forecast, By Application
- 7.3.1 HIV
- 7.3.2 Hepatitis
- 7.3.3 Herpes
- 7.3.4 Influenza
- 7.3.5Others
- 8 Global Antiviral Drugs Market, By Region
- 8.1 Global Antiviral Drugs Market Share Analysis, By Region
- 8.2 Global Antiviral Drugs Market Share Analysis, By Region
- 8.3 Global Antiviral Drugs Market Size and Forecast, By Region
- 9 North America Antiviral Drugs Market Analysis and Forecast (2021-2027)
- 9.1 Introduction
- 9.2 North America Antiviral Drugs Market Share Analysis, By Drug Class
- 9.3 North America Antiviral Drugs Market Size and Forecast, By Type
- 9.4 North America Antiviral Drugs Market Size and Forecast, By Application
- 9.6 North America Antiviral Drugs Market Size and Forecast, By Country
- 9.7.1 U.S.
- 9.7.2 Canada
- 9.7.3 Mexico
- 10 Europe Antiviral Drugs Market Analysis and Forecast (2021-2027)
- 10.1 Introduction
- 10.2 Europe Antiviral Drugs Market Share Analysis, By Drug Class
- 10.3 Europe Antiviral Drugs Market Size and Forecast, By Type
- 10.4 Europe Antiviral Drugs Market Size and Forecast, By Application
- 10.6 Europe Antiviral Drugs Market Size and Forecast, By Country
- 10.6.1 Germany
- 10.6.2 France
- 10.6.3 UK
- 10.6.4. Rest of Europe
- 11 Asia Pacific Antiviral Drugs Market Analysis and Forecast (2021-2027)
- 11.1 Introduction
- 11.2 Asia Pacific Antiviral Drugs Market Share Analysis, By Drug Class
- 11.3 Asia Pacific Antiviral Drugs Market Size and Forecast, By Type
- 11.4 Asia Pacific Antiviral Drugs Market Size and Forecast, By Application
- 11.6 Asia Pacific Antiviral Drugs Market Size and Forecast, By Country
- 11.6.1 China
- 11.7.2 Japan
- 11.8.3 India
- 11.8.4. Rest of Asia Pacific
- 12 Latin America Antiviral Drugs Market Analysis and Forecast (2021-2027)
- 12.1 Introduction
- 12.2 Latin America Antiviral Drugs Market Share Analysis, By Drug Class
- 12.3 Latin America Antiviral Drugs Market Size and Forecast, By Type
- 12.4 Latin America Antiviral Drugs Market Size and Forecast, By Application
- 12.6 Latin America Antiviral Drugs Market Size and Forecast, Country
- 12.7.1. Brazil
- 12.8.2. Rest of Latin America
- 13 Middle East Antiviral Drugs Market Analysis and Forecast (2021-2027)
- 13.1 Introduction
- 13.2 Middle East Antiviral Drugs Market Share Analysis, By Drug Class
- 13.3 Middle East Antiviral Drugs Market Size and Forecast, By Type
- 13.4 Middle East Antiviral Drugs Market Size and Forecast, By Application
- 13.6 Middle East Antiviral Drugs Market Size and Forecast, By Country
- 13.7.1. Saudi Arabia
- 13.8.2. UAE
- 13.8.3. Egypt
- 13.9.4. Kuwait
- 13.10.5. South Africa
- 14 Competitive Analysis
- 14.1 Competition Dashboard
- 14.2 Market share Analysis of Top Vendors
- 14.3 Key Development Strategies
- 15 Company Profiles
- 15.1 Gilead Sciences, Inc
- 15.1.1 Overview
- 15.1.2 Drug Classs
- 15.1.3 Key Financials
- 15.1.4 Business Segment & Geographic Overview
- 15.1.5 Key Market Developments
- 15.1.6 Key Strategies
- 15.2. GlaxoSmithKline plc
- 15.2.1 Overview
- 15.2.2 Drug Classs
- 15.2.3 Key Financials
- 15.2.4 Business Segment & Geographic Overview
- 15.2.5 Key Market Developments
- 15.2.6 Key Strategies
- 15.3. F. Hoffmann-La Roche Ltd
- 15.3.1 Overview
- 15.3.2 Drug Classs
- 15.3.3 Key Financials
- 15.3.4 Business Segment & Geographic Overview
- 15.3.5 Key Market Developments
- 15.3.6 Key Strategies
- 15.4 AbbVie Inc
- 15.4.1 Overview
- 15.4.2 Drug Classs
- 15.4.3 Key Financials
- 15.4.4 Business Segment & Geographic Overview
- 15.4.5 Key Market Developments
- 15.4.6 Key Strategies
- 15.5 Merck & Co., Inc
- 15.5.1 Overview
- 15.5.2 Drug Classs
- 15.5.3 Key Financials
- 15.5.4 Business Segment & Geographic Overview
- 15.5.5 Key Market Developments
- 15.5.6 Key Strategies
- 15.6 Johnson & Johnson Services, Inc.
- 15.6.1 Overview
- 15.6.2 Drug Classs
- 15.6.3 Key Financials
- 15.6.4 Business Segment & Geographic Overview
- 15.6.5 Key Market Developments
- 15.6.6 Key Strategies
- 15.7 Cipla Inc
- 15.7.1 Overview
- 15.7.2 Drug Classs
- 15.7.3 Key Financials
- 15.7.4 Business Segment & Geographic Overview
- 15.7.5 Key Market Developments
- 15.7.6 Key Strategies
- 15.8 Aurobindo Pharma
- 15.8.1 Overview
- 15.8.2 Drug Classs
- 15.8.3 Key Financials
- 15.8.4 Business Segment & Geographic Overview
- 15.8.5 Key Market Developments
- 15.8.6 Key Strategies
- 15.9 Dr. Reddy’s Laboratories Ltd
- 15.9.1 Overview
- 15.9.2 Drug Classs
- 15.9.3 Key Financials
- 15.9.4 Business Segment & Geographic Overview
- 15.9.5 Key Market Developments
- 15.9.6 Key Strategies
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook